K-numberK243032
Device nameEHL Probe (SCDG-AS); EHL Probe (SCDG-BS); EHL Probe (SCDG-CS)
ApplicantGuangzhou Potent Medical Equipment Joint-Stock Co., Ltd.
Product codeFFK
Device classClass II
Decision dateMar 21, 2025
DecisionSubstantially Equivalent
Regulation876.4480
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The EHL probe (SCDG-AS, SCDG-BS, SCDG-CS) is a sterile, single-use electrohydraulic lithotripsy device designed to fragment biliary stones in the bile duct. It delivers low-energy electrical pulses through a connection to the TCS-B3-II electrohydraulic lithotripter, generating hydraulic shock waves in saline to disintegrate bile duct stones.

Technological characteristics

Both the subject device and predicate (EL27-Compact, K230488) use identical electrohydraulic shock wave mechanisms for stone fragmentation with biocompatible materials and single-use sterile design. The subject device is dimensionally smaller in total length, energy output line, electrode length, and probe diameter, but maintains identical structural composition, similar materials, and the same energy delivery mechanism with validated equivalent performance.

Test standards cited

ISO 10993-1 (biocompatibility), ISO 10993-5, ISO 10993-10, ISO 10993-23, ISO 10993-11 (biocompatibility testing), IEC 61846 (shock wave characterization and pressure attenuation), IEC 60601-1 (electrical safety), IEC 60601-1-2 (EMC requirements), ASTM F1980 (aging/durability testing).

Substantial equivalence argument

The subject device is substantially equivalent because it employs the identical electrohydraulic lithotripsy mechanism as the predicate, uses the same biocompatible materials and sterilization method (ethylene oxide), and achieves equivalent performance through bench testing including shock wave efficacy, stone fragmentation, tissue perforation, and electrical safety. Although dimensionally smaller, the minor dimensional differences do not compromise functionality given identical structural composition and validated performance equivalence, thus raising no new safety or effectiveness questions.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →